Oncology
1 AI tool 7 articles
Advertisement
AI tools1
Articles7
Melanoma Immunotherapy Left Half of Patients With Lasting Side Effects. A Study Asks Who.
In 303 patients treated after surgery, 48% had side effects that persisted after stopping, most often thyroid...
AM
3 Oct
A Drug Aimed at a Weak Point in Some Cancers Shrank Tumours in 7 of 66 Patients
The first WRN inhibitor tested in people was tolerable and controlled disease in 74% of patients whose MSI can...
AM
30 Sep
In a Rare Kidney Cancer, PET Redrew One in Five Treatment Plans
Forty-nine patients, a tumour that kills in around fourteen months, and a scan that found what conventional im...
AM
19 Sep
Roche's Lymphoma Trial Succeeded. It Did Not Say by How Much.
A confirmatory Phase III delivered what was promised when the drug was let through early. The number describin...
AM
19 Sep
A Pancreatic Cancer Blood Test Misfires Most in the Group It Is For
PANXEON detected 86.8 per cent of stage I and II disease across 1,649 patients. Its false-positive rate is fiv...
AM
18 Sep
An AI Lung-Cancer Tool Beat PD-L1, Then Faltered on New Patients
I3LUNG beat five standard biomarkers on its own test set. In external validation the range was 0.55 to 0.72, a...
AM
17 Sep
FDA Clears ArteraAI Breast: The First AI Digital Pathology Tool to Stratify Breast Cancer Metastasis Risk
On 6 May 2026, ArteraAI Breast became the first FDA-cleared digital pathology tool to stratify early-stage bre...
AM
2 Jun
Advertisement